Electromed (NYSEAMERICAN:ELMD) Stock Crosses Above Two Hundred Day Moving Average of $0.00

Electromed, Inc. (NYSEAMERICAN:ELMDGet Rating) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $11.37. Electromed shares last traded at $10.94, with a volume of 24,082 shares changing hands.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ELMD shares. Eurobank EFG started coverage on shares of Electromed in a report on Tuesday, September 6th. They issued a “buy” rating for the company. EF Hutton Acquisition Corp I began coverage on shares of Electromed in a research note on Tuesday, September 6th. They set a “buy” rating and a $13.50 target price for the company. Finally, Lake Street Capital began coverage on shares of Electromed in a research note on Friday, August 5th. They set a “buy” rating and a $20.00 target price for the company. Four analysts have rated the stock with a buy rating, According to MarketBeat, Electromed currently has a consensus rating of “Buy” and an average price target of $17.83.

Electromed Stock Performance

The company has a market cap of $92.38 million, a PE ratio of 43.60, a PEG ratio of 4.16 and a beta of 0.65.

Electromed (NYSEAMERICAN:ELMDGet Rating) last released its quarterly earnings results on Tuesday, August 23rd. The medical equipment provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.04). Electromed had a return on equity of 6.94% and a net margin of 6.00%. As a group, research analysts anticipate that Electromed, Inc. will post 0.31 EPS for the current year.

Institutional Trading of Electromed

Hedge funds and other institutional investors have recently made changes to their positions in the business. Corsair Capital Management L.P. acquired a new stake in shares of Electromed during the fourth quarter valued at approximately $195,000. Cetera Advisor Networks LLC acquired a new stake in shares of Electromed during the second quarter valued at approximately $129,000. Riverwater Partners LLC raised its holdings in shares of Electromed by 49.4% during the first quarter. Riverwater Partners LLC now owns 29,417 shares of the medical equipment provider’s stock valued at $366,000 after acquiring an additional 9,729 shares during the period. Vanguard Group Inc. raised its holdings in shares of Electromed by 2.6% during the first quarter. Vanguard Group Inc. now owns 310,200 shares of the medical equipment provider’s stock valued at $3,859,000 after acquiring an additional 7,742 shares during the period. Finally, Annex Advisory Services LLC raised its holdings in shares of Electromed by 32.5% during the first quarter. Annex Advisory Services LLC now owns 21,020 shares of the medical equipment provider’s stock valued at $261,000 after acquiring an additional 5,158 shares during the period. 39.67% of the stock is currently owned by institutional investors.

About Electromed

(Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

Featured Articles

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.